Abstract:The responsiveness of glucose sensing per se to regulate whole-body glucose homeostasis is dependent on the ability of a rise in glucose to lower hepatic glucose production and increase peripheral glucose uptake in vivo. In both rodents and humans, glucose sensing is lost in diabetes and obesity but the site(s) of impairment remain elusive. We here first report that short-term high-fat feeding dirsupts hypothalamic glucose sensing to lower glucose production in rats. Second, leptin administration into the hypothalamus of high-fat fed rats restored hypothalamic glucose sensing to lower glucose production during a pancreatic (basal insulin)-euglycemic clamp and increased wholebody glucose tolerance during an intravenous glucose tolerance test. Finally, both chemical inhibition of hypothalamic lactate dehydrogenase (LDH) (achieved via hypothalamic LDH inhibitor oxamate infusion) and molecular knockdown of LDHA (achieved via hypothalamic lentiviral-LDHA shRNA injection) negated the ability of hypothalamic leptin infusion to enhance glucose sensing to lower glucose production in high-fat fed rats. In summary, our findings illustrate that leptin enhances LDH-A-dependent glucose sesning in the hypothalamus to lower glucose production in highfat fed rodents in vivo.The hallmark feature of Type 2 diabetes is traditionally viewed as insulin resistance resulting in elevated hepatic glucose production and impaired glucose uptake in peripheral tissues. However, a change in glucose responsiveness as defined as the ability of glucose sensing per se in regulating glucose production and uptake could also potentially contribute to glucose dysregulation in diabetes.For instance, studies conducted in both rodents and humans report that independent of changes in glucoregulatory hormones during the pancreatic clamps, a doubling of circulating glucose levels inhibits glucose production and stimulates peripheral glucose uptake in healthy conditions (1-3). However, the same increment in the plasma glucose levels fail to lower glucose production in diabetic rodents (1) and humans (2,3), thereby illustrating glucose unresponsiveness as a feature in diabetic conditions. Glucose unresponsiveness in obese individuals has been determined from a mathematical minimal model analysis following a frequently sampled intravenous (ivGTT) or oral glucose tolerance test. Indeed, a reduction in glucose responsiveness was associated with impaired glucose tolerance in obese individuals (4). As seen in humans, obese and diabetic rodents such as the leptin deficient ob/ob mice also display a loss of glucose sensing (5). Thus, the ability of glucose sensing per se to regulate its own metabolism is highly relevant in obesity and diabetes.To date, the site(s) of glucose sensing impairment that lead to glucose unresponsiveness in obesity and diabetes remain elusive. In this regard, a hypothalamic glucose sensing mechanism has been documented to maintain glucose homeostasis in the context of hypoglycemic-induced counter regulation (6) as well as short-t...